AAPL332.41+1.07 (+0.32%) ▲|ABBV262.51-0.53 (-0.20%) ▼|ABT102.36+0.33 (+0.32%) ▲|ACN189.64-3.76 (-1.94%) ▼|ADBE250.50-7.26 (-2.82%) ▼|AMAT415.38-5.79 (-1.37%) ▼|AMD512.50+8.30 (+1.65%) ▲|AMGN376.35+0.70 (+0.19%) ▲|AMT176.39-1.32 (-0.74%) ▼|AMZN245.96-2.46 (-0.99%) ▼|AVGO339.51+0.24 (+0.07%) ▲|AXP312.43-12.00 (-3.70%) ▼|BA201.96-7.73 (-3.69%) ▼|BAC57.90-1.62 (-2.72%) ▼|BKNG171.40+0.08 (+0.05%) ▲|BLK1,037.24-21.42 (-2.02%) ▼|BMY63.60-0.13 (-0.20%) ▼|BNY153.47-1.20 (-0.78%) ▼|BRK-B519.80+3.04 (+0.59%) ▲|C132.95-3.22 (-2.36%) ▼|CAT782.72-0.82 (-0.10%) ▼|CL87.02+0.02 (+0.02%) ▲|CMCSA23.73-0.69 (-2.83%) ▼|COF203.19-3.66 (-1.77%) ▼|COP132.54-8.68 (-6.15%) ▼|COST893.74-7.61 (-0.84%) ▼|CRM250.54-5.11 (-2.00%) ▼|CSCO107.74-2.33 (-2.12%) ▼|CVS91.72-2.77 (-2.93%) ▼|CVX211.54-6.23 (-2.86%) ▼|DE669.47-14.57 (-2.13%) ▼|DHR208.36-1.00 (-0.48%) ▼|DIS106.99+0.57 (+0.54%) ▲|DUK117.76-0.01 (-0.01%) ▼|EMR145.83-1.17 (-0.80%) ▼|FDX301.72-6.54 (-2.12%) ▼|GD360.00+1.40 (+0.39%) ▲|GE312.90+5.85 (+1.91%) ▲|GEV925.09+42.28 (+4.79%) ▲|GILD147.68+1.38 (+0.94%) ▲|GM84.29-1.08 (-1.27%) ▼|GOOG339.36-2.07 (-0.61%) ▼|GOOGL342.87-2.11 (-0.61%) ▼|GS937.98-38.69 (-3.96%) ▼|HD302.47-3.01 (-0.99%) ▼|HON207.66+4.22 (+2.07%) ▲|IBM237.49-10.88 (-4.38%) ▼|INTC101.05+3.91 (+4.03%) ▲|INTU318.13-11.14 (-3.38%) ▼|ISRG382.29+5.13 (+1.36%) ▲|JNJ267.28+0.08 (+0.03%) ▲|JPM348.92-3.57 (-1.01%) ▼|KO87.87-0.84 (-0.95%) ▼|LIN462.09-0.87 (-0.19%) ▼|LLY1,137.82+1.71 (+0.15%) ▲|LMT537.25+3.79 (+0.71%) ▲|LOW194.10-0.51 (-0.26%) ▼|LRCX269.23-1.64 (-0.61%) ▼|MA567.75-5.52 (-0.96%) ▼|MCD248.56-4.22 (-1.67%) ▼|MDLZ62.36+0.26 (+0.42%) ▲|MDT92.60-1.15 (-1.23%) ▼|META673.31+3.07 (+0.46%) ▲|MMM162.65-2.02 (-1.23%) ▼|MO70.10+0.29 (+0.42%) ▲|MRK144.91+1.12 (+0.78%) ▲|MS202.42-3.86 (-1.87%) ▼|MSFT490.30-6.82 (-1.37%) ▼|MU926.55-1.05 (-0.11%) ▼|NEE80.37-0.70 (-0.86%) ▼|NFLX76.41-1.49 (-1.91%) ▼|NKE35.78-0.44 (-1.21%) ▼|NOW139.82-2.08 (-1.47%) ▼|NVDA213.90+1.73 (+0.82%) ▲|ORCL143.16+2.81 (+2.00%) ▲|PEP134.34-1.16 (-0.86%) ▼|PFE27.46-0.09 (-0.33%) ▼|PG147.02+0.35 (+0.24%) ▲|PLTR174.34+1.78 (+1.03%) ▲|PM191.71-2.40 (-1.24%) ▼|QCOM184.84-2.96 (-1.58%) ▼|RTX196.83+1.33 (+0.68%) ▲|SBUX97.34+0.76 (+0.79%) ▲|SCHW105.16-2.63 (-2.44%) ▼|SO86.23+0.28 (+0.33%) ▲|SPG202.94-1.16 (-0.57%) ▼|T25.86-0.86 (-3.22%) ▼|TMO648.43+7.04 (+1.10%) ▲|TMUS176.26-4.21 (-2.33%) ▼|TSLA358.08+1.50 (+0.42%) ▲|TXN260.67-2.76 (-1.05%) ▼|UBER70.97-0.46 (-0.64%) ▼|UNH375.26-0.67 (-0.18%) ▼|UNP280.92-3.07 (-1.08%) ▼|UPS98.77-3.58 (-3.50%) ▼|USB59.73-2.49 (-4.00%) ▼|V370.93-4.69 (-1.25%) ▼|VZ49.76-1.69 (-3.28%) ▼|WFC87.05-2.67 (-2.98%) ▼|WMT107.50-0.59 (-0.55%) ▼|XOM163.32-6.00 (-3.54%) ▼|AAPL332.41+1.07 (+0.32%) ▲|ABBV262.51-0.53 (-0.20%) ▼|ABT102.36+0.33 (+0.32%) ▲|ACN189.64-3.76 (-1.94%) ▼|ADBE250.50-7.26 (-2.82%) ▼|AMAT415.38-5.79 (-1.37%) ▼|AMD512.50+8.30 (+1.65%) ▲|AMGN376.35+0.70 (+0.19%) ▲|AMT176.39-1.32 (-0.74%) ▼|AMZN245.96-2.46 (-0.99%) ▼|AVGO339.51+0.24 (+0.07%) ▲|AXP312.43-12.00 (-3.70%) ▼|BA201.96-7.73 (-3.69%) ▼|BAC57.90-1.62 (-2.72%) ▼|BKNG171.40+0.08 (+0.05%) ▲|BLK1,037.24-21.42 (-2.02%) ▼|BMY63.60-0.13 (-0.20%) ▼|BNY153.47-1.20 (-0.78%) ▼|BRK-B519.80+3.04 (+0.59%) ▲|C132.95-3.22 (-2.36%) ▼|CAT782.72-0.82 (-0.10%) ▼|CL87.02+0.02 (+0.02%) ▲|CMCSA23.73-0.69 (-2.83%) ▼|COF203.19-3.66 (-1.77%) ▼|COP132.54-8.68 (-6.15%) ▼|COST893.74-7.61 (-0.84%) ▼|CRM250.54-5.11 (-2.00%) ▼|CSCO107.74-2.33 (-2.12%) ▼|CVS91.72-2.77 (-2.93%) ▼|CVX211.54-6.23 (-2.86%) ▼|DE669.47-14.57 (-2.13%) ▼|DHR208.36-1.00 (-0.48%) ▼|DIS106.99+0.57 (+0.54%) ▲|DUK117.76-0.01 (-0.01%) ▼|EMR145.83-1.17 (-0.80%) ▼|FDX301.72-6.54 (-2.12%) ▼|GD360.00+1.40 (+0.39%) ▲|GE312.90+5.85 (+1.91%) ▲|GEV925.09+42.28 (+4.79%) ▲|GILD147.68+1.38 (+0.94%) ▲|GM84.29-1.08 (-1.27%) ▼|GOOG339.36-2.07 (-0.61%) ▼|GOOGL342.87-2.11 (-0.61%) ▼|GS937.98-38.69 (-3.96%) ▼|HD302.47-3.01 (-0.99%) ▼|HON207.66+4.22 (+2.07%) ▲|IBM237.49-10.88 (-4.38%) ▼|INTC101.05+3.91 (+4.03%) ▲|INTU318.13-11.14 (-3.38%) ▼|ISRG382.29+5.13 (+1.36%) ▲|JNJ267.28+0.08 (+0.03%) ▲|JPM348.92-3.57 (-1.01%) ▼|KO87.87-0.84 (-0.95%) ▼|LIN462.09-0.87 (-0.19%) ▼|LLY1,137.82+1.71 (+0.15%) ▲|LMT537.25+3.79 (+0.71%) ▲|LOW194.10-0.51 (-0.26%) ▼|LRCX269.23-1.64 (-0.61%) ▼|MA567.75-5.52 (-0.96%) ▼|MCD248.56-4.22 (-1.67%) ▼|MDLZ62.36+0.26 (+0.42%) ▲|MDT92.60-1.15 (-1.23%) ▼|META673.31+3.07 (+0.46%) ▲|MMM162.65-2.02 (-1.23%) ▼|MO70.10+0.29 (+0.42%) ▲|MRK144.91+1.12 (+0.78%) ▲|MS202.42-3.86 (-1.87%) ▼|MSFT490.30-6.82 (-1.37%) ▼|MU926.55-1.05 (-0.11%) ▼|NEE80.37-0.70 (-0.86%) ▼|NFLX76.41-1.49 (-1.91%) ▼|NKE35.78-0.44 (-1.21%) ▼|NOW139.82-2.08 (-1.47%) ▼|NVDA213.90+1.73 (+0.82%) ▲|ORCL143.16+2.81 (+2.00%) ▲|PEP134.34-1.16 (-0.86%) ▼|PFE27.46-0.09 (-0.33%) ▼|PG147.02+0.35 (+0.24%) ▲|PLTR174.34+1.78 (+1.03%) ▲|PM191.71-2.40 (-1.24%) ▼|QCOM184.84-2.96 (-1.58%) ▼|RTX196.83+1.33 (+0.68%) ▲|SBUX97.34+0.76 (+0.79%) ▲|SCHW105.16-2.63 (-2.44%) ▼|SO86.23+0.28 (+0.33%) ▲|SPG202.94-1.16 (-0.57%) ▼|T25.86-0.86 (-3.22%) ▼|TMO648.43+7.04 (+1.10%) ▲|TMUS176.26-4.21 (-2.33%) ▼|TSLA358.08+1.50 (+0.42%) ▲|TXN260.67-2.76 (-1.05%) ▼|UBER70.97-0.46 (-0.64%) ▼|UNH375.26-0.67 (-0.18%) ▼|UNP280.92-3.07 (-1.08%) ▼|UPS98.77-3.58 (-3.50%) ▼|USB59.73-2.49 (-4.00%) ▼|V370.93-4.69 (-1.25%) ▼|VZ49.76-1.69 (-3.28%) ▼|WFC87.05-2.67 (-2.98%) ▼|WMT107.50-0.59 (-0.55%) ▼|XOM163.32-6.00 (-3.54%) ▼|
22.8 C
New York
Thursday, September 17, 2026

Tag: technology

newssourceFORcompanyinformationcontent1releasesmarket

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy...

CAMBRIDGE, Mass., June 15, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced three-year follow-up data from the Phase 1 portion of the ongoing Phase 1/2 study in patients with HAE after receiving a single dose of lonvoguran ziclumeran (lonvo-z, also known as NTLA-2002). Results were shared in an oral presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, held June 13-16 in Glasgow, United Kingdom.

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DoubleVerify

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In DoubleVerify To Contact Him Directly To...

Scatec signs PPA for 900MW onshore wind project in Egypt

Oslo/Cairo, 15 June 2025: Scatec ASA, a leading renewable energy solutions provider, has signed a USD-denominated 25-year Power Purchase Agreement (PPA) with the Egyptian Electricity Transmission Company (EETC) for a 900 MW wind project, through its dedicated project company “Shadwan Wind Power SAE” to accelerate Egypt’s transition towards a greener and more sustainable energy mix.

Redtiger Celebrates 5 Years of Bestselling Dash Cams for Cars With Discounts, Giveaways, and More

Marking five years of empowering drivers and vehicle owners to keep themselves and their passengers safe on the road, Redtiger is celebrating the anniversary with...

Zilliz Transforms Video Surveillance Industry with AI-Powered Vector Database Solutions

Leading surveillance providers leverage Zilliz Cloud to overcome data overload challenges, enabling real-time threat detection and sub-second video search across enterprise installations. REDWOOD SHORES, Calif.,...

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for...

Media Release

COPENHAGEN, Denmark; June 15, 2025

Eve Air Mobility and Revo Accelerate Urban Air Mobility with $250M Contract

A fleet of up to 50 aircraft and aftermarket services is poised to revolutionize urban transport across Revo's key markets. PARIS, June 15, 2025 /PRNewswire/ -- Eve Air Mobility ("Eve") (NYSE: EVEX) (NYSE: EVEXW) has signed its first binding framework agreement with...

Eve Air Mobility Twenty-Year Market Outlook Highlights Growth of Urban Air Mobility Globally

Outlook highlights a $280 billion passenger revenue and 30,000 aircraft opportunities driven by urban population growth, traffic concerns, and a commitment to sustainability. PARIS,...

China, Central Asia make continuous efforts to deepen agricultural cooperation

BEIJING, June 15, 2025 /PRNewswire/ -- A report from People's Daily: ...

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients

Basel, 15 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new dosing restrictions, effective immediately, for ELEVIDYS™ (delandistrogene moxeparvovec), for non-ambulatory Duchenne muscular dystrophy (DMD) patients, irrespective of age, in both clinical and commercial settings. In the commercial setting, non-ambulatory patients should no longer receive Elevidys. In the clinical trial setting, enrolment and dosing of non-ambulatory patients will be immediately paused until additional risk mitigation measures (e.g. immune modulatory treatment) are implemented in the study protocol. Health authorities, investigators and physicians are being informed so that patient care can be quickly adjusted.

Hisense Celebrates Kick-off of FIFA Club World Cup™ as Official Partner, Marking New Milestone in Global Sports Journey

QINGDAO, China, June 14, 2025 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, celebrates the opening of the FIFA...

Cheap AI Bots Eye Junior Coders’ Lunch

In 2007, Luke Arrigoni pulled in $63,000 as a junior software developer. Fast forward to today, and AI tools that supposedly churn out better...

Nuclear Air Filtration for HVAC Managers: Why the Nuclear Comeback Demands Next-Gen Filtration Standards

The Big Reveal: What HVAC Managers Must Know About High-Performance Filtration. Camfil Nuclear air filters are used for containment control during dismantling or maintenance work at a nuclear sites. 
The Big Reveal:  What HVAC Managers Must Know About High-Performance Filtration. Camfil Nuclear air filters are used for containment control during dismantling or maintenance work at a nuclear sites.

PFMCrypto’s “1-Day Mining Contract” Sales Surge 76% – $1 Million Giveaway Ignites Community Buzz

As PFMCrypto’s AI-driven mining model gains momentum, the platform celebrates a major milestone with a global bonus campaign for new users 
As PFMCrypto’s AI-driven mining model gains momentum, the platform celebrates a major milestone with a global bonus campaign for new users

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTechnology

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers